Get notified of page updates
Education > XRAY > Search Results

FORCE's eXamining the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you. XRAY is a reliable source of hereditary cancer research-related news and information.
Learn more about the XRAY program

How To Use XRAY
Search by Topic Submit an Article for Review

All XRAYs

21 through 30 of 311

Relevance: Medium-High

Research Timeline: Post Approval

View Related Clinical Trials

Update : New first-line treatment option for metastatic prostate cancer

Relevance: Medium-High

Research Timeline: Post Approval

View Related Clinical Trials

Most relevant for: People with metastatic castration resistant prostate cancer who have an inherited or tumor mutation in certain genes.

The FDA has approved Talzenna (talazoparib) with Xtandi (enzalutamide) as first-line treatments for some patients with metastatic castration-resistant prostate cancer. (Posted 10/2/23)

Este artículo está disponible en español.

Read More

Relevance: Medium-High

Research Timeline: Human Research

View Related Clinical Trials

Article : Artificial intelligence (AI) may find breast cancer on mammograms sooner

Relevance: Medium-High

Research Timeline: Human Research

View Related Clinical Trials

Most relevant for: People interested in the use of artificial intelligence in medicine

Artificial intelligence (AI) tools may help doctors read mammograms. This assistance may lead to earlier diagnoses of breast cancer. (Posted 9/29/23)

Este artículo está disponible en español.

Read More

Relevance: High

Quality of Writing: Medium-High

Article : Genetic testing and the future of medicine

Relevance: High

Quality of Writing: Medium-High

Most relevant for: People interested in genetic testing.

An article published in Katie Couric Media discusses genetic testing and how it can impact health. The author talked with Dr. Robert Steiner, a doctor who specializes in genetics. He talked about genetic testing and how the results can affect health and change lives. (Posted 9/28/23)

Este artículo está disponible en español.

Read More

Relevance: Medium-High

Quality of Writing: High

Topic : Sexual health concerns of gay and bisexual men with prostate cancer

Relevance: Medium-High

Quality of Writing: High

Most relevant for: Gay and bisexual men diagnosed with prostate cancer

Prostate cancer therapy can affect gay and bisexual men differently than heterosexual men. Many urologists do not routinely address these unique concerns. Selecting providers who understand the concerns that are unique to gay and bisexual patients and asking questions about sexual health concerns may improve these patients' healthcare experiences. (Posted 9/21/23)

Este artículo está disponible en español.

Read More

Relevance: Medium-High

Research Timeline: Post Approval

View Related Clinical Trials

Update : New drug combination for early treatment of some metastatic prostate cancer

Relevance: Medium-High

Research Timeline: Post Approval

View Related Clinical Trials

Most relevant for: People with metastatic castration resistant prostate cancer with a mutation in BRCA1 or BRCA2

The FDA approved Lynparza (olaparib) for use earlier in treatment of metastatic castration-resistant prostate cancer (mCRPC) when added to abiraterone and prednisone for people with a BRCA mutation found through genetic or tumor testing. Lynparza combined with hormone therapy may now be used as a first-line or later treatment. (Posted 9/11/23)

Este artículo está disponible en español.

Read More

Relevance: Medium-Low

Quality of Writing: Medium

Research Timeline: Animal Studies

View Related Clinical Trials

Article : Promising drug for cancer treatment begins clinical trials

Relevance: Medium-Low

Quality of Writing: Medium

Research Timeline: Animal Studies

View Related Clinical Trials

Most relevant for: People with solid tumors.

Researchers at City of Hope are testing a new type of cancer treatment drug. When tested in animals and cells taken from human cancers, this new drug prevented the growth of many types of cancer. Initial clinical trials in people have just started. (Posted 9/7/23)

Este artículo está disponible en español.

Read More

Relevance: Medium-High

Strength of Science: Medium-High

Research Timeline: Human Research

View Related Clinical Trials

Study : Personalized vaccines may help pancreatic cancer treatment

Relevance: Medium-High

Strength of Science: Medium-High

Research Timeline: Human Research

View Related Clinical Trials

Most relevant for: People with pancreatic cancer who have tumors that can be removed by surgery

Pancreatic cancer is usually diagnosed at a late stage when patients have few treatment options. Early study results showed that a pancreatic cancer vaccine delayed the return of cancer for nearly half of the participants. (Posted 8/29/23)

Este artículo está disponible en español.

Read More

Relevance: Medium-High

View Related Clinical Trials

Topic : Colorectal cancer is on the rise in young adults: What Millennials and Gen Zs need to know

Relevance: Medium-High

View Related Clinical Trials

Most relevant for: Young adults

The rate of colorectal cancer among young adults in the US has been increasing since the 1990s. Scientists are trying to figure out why. (Posted 8/15/23)

Este artículo está disponible en español.

Read More

Relevance: Medium-High

View Related Clinical Trials

Topic : Sex and intimacy after breast cancer

Relevance: Medium-High

View Related Clinical Trials

Most relevant for: People with breast cancer or metastatic breast cancer in sexual or intimate relationships and their partners

A breast cancer diagnosis and treatment can affect relationships with romantic partners. This review highlights two studies that looked at how people with breast cancer and their partners are affected, how they cope, how best to communicate with each other and how to talk with healthcare providers about concerns related to cancer and sexuality. (Posted 8/8/23)

Este artículo está disponible en español.

Read More

Relevance: Medium-High

Strength of Science: High

Research Timeline: Post Approval

View Related Clinical Trials

Study : New treatment option for advanced or recurrent endometrial cancer

Relevance: Medium-High

Strength of Science: High

Research Timeline: Post Approval

View Related Clinical Trials

Most relevant for: People with advanced or recurrent endometrial cancer

If you have advanced or recurrent endometrial cancer, there is a new treatment called Jemperli (dostarlimab) that could be an option for you. This study looked at how well Jemperli worked compared to standard treatment. Based on these results, the Food and Drug Administration (FDA) approved the combination of Jemperli and chemotherapy for certain types of advanced endometrial cancer. (Posted 8/4/23)

Este artículo está disponible en español.

Read More